IBA announced that longtime customer and research partner Penn Medicine has upgraded the equipment of its Roberts Proton Therapy Center with the latest innovations in proton therapy treatment. This upgrade to the newest technologies will allow Penn Medicine’s staff to continue to offer top-level proton radiation therapy services to an increasing number of patients and to further advance the clinical application of proton therapy.
Mach7 Technologies and 3D Medical Limited announced yesterday they have signed a definitive agreement to merge together. The merger will provide access via public capital markets for Mach7 while preserving corporate self-determination with regard to mission and product roadmap. Upon approval and completion of the agreement, the merged entity will be publicly listed on the Australian stock exchange (ASX) and will trade as "Mach7 Technologies Ltd."
Carestream Health earned the top rating in MD Buyline’s Market Intelligence Briefing (Q3 2015) for both portable and room-based digital X-ray systems for the third time this year. The company’s DRX-Revolution mobile X-ray system and its DRX-Evolution and DRX-Ascend systems scored high marks from healthcare providers for performance, reliability, installation and service quality.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Healthcare technology company MphRx will debut a new platform at the Radiological Society of North America (RSNA) 2015 annual meeting that enables transmission of detailed patient forms, images and records from any computer for review by providers and automated ingestion into an EMR, PACS or RIS.
University of Missouri researchers have developed a new scoring system for a common lung cancer diagnostic test that may help physicians better understand the risk for malignancy when evaluating patients.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
New data from clinical trials conducted at Penn Medicine’s Robert Proton Therapy Center demonstrate the technology's potential advantages over conventional radiation, including less side effects and survival in some cases, for several harder-to-treat tumors. This includes pancreatic, late-stage non-small cell lung and chordoma and chondrosarcoma, two rare cancers found in bone or soft tissue.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
IBA announced that a breast cancer patient at Willis-Knighton Cancer Center has received the first U.S. Food and Drug Administration (FDA)-approved compact proton therapy treatment with cone beam computed tomography (CBCT). The treatment was completed using IBA’s Proteus One system.
Patients with intermediate meningiomas treated with radiation therapy (RT) after surgery experienced a 96 percent three-year progression-free survival rate and had minimal adverse events, according to new research. Study findings were presented at the American Society for Radiation Oncology’s (ASTRO’s) 57th annual meeting.
Candescent Health launched a software-enabled service that will allow radiologists to optimize clinical performance, increase efficiencies and deliver the most efficient and effective quality of care. Candescent was born out of 10 years of experience managing a radiology practice that achieved quality and efficiency metrics well above all industry standards. The Candescent team is now applying their expertise and technology to enable additional radiology groups to significantly optimize their care delivery models.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
For patients with locally advanced esophageal cancer that has spread to the lymph nodes, radiation therapy (RT) targeting only the involved lymph nodes regions results in less toxicity without causing a statistically significant difference in loco-regional lymph nodal recurrence, distant failure and overall survival rates, according to new research. Study findings were presented at the American Society for Radiation Oncology’s (ASTRO’s) 57th annual meeting.
The idea behind clinical decision support (CDS) is simple — ensure that tests or procedures ordered by referring ...
Outcomes for pediatric patients as young as 12 months with ependymoma who are treated with immediate post-operative radiation therapy are favorable and consistent based upon the patients’ tumor surgical resection and tumor grade, according to new research. Findings from the study were presented at the American Society for Radiation Oncology’s (ASTRO’s) 57th annual meeting.
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
The steroid dexamethasone reduces radiation-induced pain flare in cancer patients with painful bone metastases, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 57th annual meeting.
Bracco Diagnostics Inc. announced that Lumason was approved by the Centers for Medicare and Medicaid Services (CMS) for pass-through status under the Hospital Outpatient Prospective Payment System (HOPPS). Lumason is an ultrasound contrast agent indicated for use in adults with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Agfa HealthCare announced it is launching its new Enterprise Imaging platform that simplifies the creation of a single comprehensive patient imaging record. The software empowers physicians to make informed decisions through multi-specialty collaboration, helping improve delivery of patient care and streamlining costs. Providing a modular approach to building and deploying, it enables organizations to move at their own pace to fulfill their enterprise strategy.
October 21, 2015 — Stage III non-small cell lung cancer (NSCLC) patients receiving intensity-modulated radiation therapy ...
iCAD Inc. presented updated clinical data, hosted in-booth clinician presentations and showcased the latest in radiation technology at the American Society for Radiation Oncology (ASTRO) meeting in San Antonio, Texas, Oct. 18-21, 2015.
A collaborative, patient reported outcome (PRO)-based approach by palliative care and radiation oncology teams results in better outpatient symptom management and a decrease in end-of-life hospitalizations and costs for late-stage cancer patients, according to new research.
An updated breast cancer screening guideline from the American Cancer Society (ACS) recommends that women at average risk start regular annual mammography screening at age 45 and transition to screening every two years starting at age 55.
IBA announced that Korea’s National Cancer Center (NCC) has recently installed and deployed its pencil beam scanning (PBS) delivery modality. On Sept. 22, PBS treatment was initiated for the first cancer patient to benefit from the superior precision of this delivery technique in Korea.